You should read the following discussion and analysis together with our
financial statements and the notes to those statements included elsewhere in
this Quarterly Report on Form 10-Q and other reports we filed with the
Securities and Exchange Commission. This Quarterly Report on Form 10-Q contains
statements that discuss future events or expectations, projections of results of
operations or financial condition, trends in our business, business prospects
and strategies and other "forward-looking" information. In some cases, you can
identify "forward-looking statements" by words like "may," "will," "should,"
"expects," "plans," "anticipates," "believes," "estimates," "predicts,"
"intends," "potential" or "continue" or the negative of those words and other
comparable words. These statements may relate to, among other things, our
ability to implement and fund our business plan; expectations for our financial
results, revenue, operating expenses and other financial measures in future
periods; and the adequacy of our sources of liquidity to satisfy our working
capital needs, capital expenditures, and other liquidity requirements.
April 2022 Reverse Merger (Purchase); Recent Developments
On February 28, 2022, Signet International Holdings, Inc. ("Signet"),? Estate of
Ernest W. Letiziano, Ms. Hope Hillabrand, and Mr. Thomas Donaldson
??(collectively, the "Controlling Shareholders") and Golden Ally Lifetech Group
Co., Ltd., a Delaware corporation ("Golden Ally") entered into a Share Purchase
and Exchange Agreement (the "SPA").
Under the SPA, the Controlling Shareholders agreed to exchange their capital
stock of Signet, consisting of 5,000,000 shares of Series A Convertible Super
Preferred Stock (convertible into 50,000,000 common shares), 4,474,080 common
shares, and $375,000? cash for all the shares of Golden Ally (the "Purchase").
The Purchase contemplated by the SPA was consummated on April 6, 2022.
Immediately after the Closing, the former stockholders of Golden Ally Sub
collectively hold beneficially and of record over 99% of the total issued and
outstanding equity securities and voting power of Signet. The Purchase resulted
in Golden Ally becoming a subsidiary of Signet and the shareholders of Golden
Ally holding shares of Signet.
In March 2022 Signet's Board of Directors approved, among other things, an
Amended and Restated Certificate of Incorporation and Amended and Restated
Bylaws, subject to stockholder approval. Stockholder approval was obtained
through written consent. On July 8, 2022, Golden Ally was merged with and into
Signet and Signet's name was from "Signet International Holdings, Inc." to
"Golden Ally Lifetech Group, Inc." In this report references to "Golden Ally" or
the "Company" refer to the operations and assets of the Company on a
post-purchase basis.
Our Business
Golden Ally is focused on its Aquaporin ("AQP") Bottled Water project, which is
a derivative of an academic inspiration from the 2003 Nobel Laureates in
Chemistry, Dr. Peter Agre and Dr. Roderick MacKinnon jointly, "for discoveries
concerning channels in cell membranes". Golden Ally has been working closely
with experienced field experts and top scientific research institutions to apply
the famous Nobel Prize theory of aquaporins into its commercialized products,
i.e., the AQP Bottled Water.
AQP Bottled Water is the product of a unique water filtration technology derived
from raw materials with exclusive access by Golden Ally. The advanced technology
can enhance water filtration for better body cell absorption to improve health.
All AQP Bottled Water products are expected to be produced through OEM
arrangements and their distribution logistics will also be supported by the OEM
partners.
AQP Bottled Water is an epoch-making product. . Golden Ally has been running
laboratory tests on its products at the David Geffen School of Medicine at
University of California, Los Angeles.
High-income households are Golden Ally's targeted consumers due to a strong
correlation between income level and health spending. The global consumer pool
for AQP Bottled Water is estimated at 17.61 million households. These households
represent the portion that has an annual household income of over $150,000 USD,
a level that can potentially support annual household spending on healthcare
products.
11
Results of Operations
Overview
Golden Ally is a developmental stage company that is currently implementing its
business plan, which is to be a high-tech start-up focused on a unique product
offering. Our activities to date have focused on the development and exploration
of water filtration technology and consumer products with AQP Bottled Water. We
have been working with field experts and research institutions to apply and
explore the ability to enhance water filtration for improved body cell
absorption in commercialized water products. During the quarter ended September
30, 2022, the Company continued taking steps to implement its business plan,
including negating various agreements related to the production, marketing and
distribution of its products, including a Supplier Agreement with Taucoin Asset
Management, LLC and a Strategic Alliance Agreement with Taucoin Asset
Management, LLC
Limited Operating History; Need for Additional Capital
We have had limited operations and have been issued a "going concern" opinion by
our auditor for the year ended December 31, 2021, based on our lack of an
established source of revenues sufficient to cover our operating costs and allow
us to continue as a going concern. As of September 30, 2022, we have incurred a
cumulative deficit of $5,042,626. There is limited historical financial
information about us upon which to base an evaluation of our performance. We
have not generated any revenues from operations. We cannot guarantee that we
will be successful in our business operations.
Our business is subject to risks inherent in the establishment of a new business
enterprise, including limited capital resources, possible delays in developing
our products and market downturns.
In the nine months ended September 30, 2022, Golden Ally received $5,042,000 for
stock subscriptions receivable related to its Common Stock. We expect to require
further outside sources of liquidity and have no assurance that future
financings will be available to us on acceptable terms, or at all. If financing
is not available on satisfactory terms, we may be unable to continue, develop or
expand our operations. Equity financing could result in additional dilution to
existing shareholders. If we are unable to raise additional capital to maintain
our operations in the future, we may be unable to carry out our business plans
or we may be forced to cease operations.
Going Concern
Our financial statements have been prepared on a going concern basis which
assumes Golden Ally will be able to realize its assets and discharge its
liabilities in the normal course of business for the foreseeable future. No
revenues have been generated to date and we expect limited revenues.
Results of Operations
During the three and nine months ended September 30, 2022, we did not generate
any revenue. Our operating expenses for the three and nine month periods ended
September 30, 2022 were $1,418,468 and $4,985,056, consisting primarily of
professional fees and other expenses paid to continue to develop and implement
marketing strategies for its products and wages and salaries for Company
personnel. As a result, for the three and nine months ended September 30, 2022,
we incurred a loss from operations of $1,418,468 and $4,985,056. During the
three and nine months ended September 30, 2021, we did not have any operations.
Liquidity and Capital Resources
Working Capital and Cash Flows. Golden Ally used cash of $5,241,613 for?
operating activities for the nine months ended September 30, 2022.
On January 3, 2022, Golden Ally entered into an agreement with a company owned
by a related party, Taucoin Asset Management LLC, to develop and implement
marketing strategies for its products and paid $1,000,000 on January 12, 2022,
per the terms of the agreement for services, and subsequently another $200,000
was paid.
On January 18, 2022, Golden Alley entered into an agreement for legal services.
In January 2022, Golden Ally paid $500,000 as a retainer to the legal service
provider.
12
Golden Ally has a lease for an office in Texas for one year at $332 per month.
During the nine months ended September 30, 2022, the Company also entered into a
lease for a location in California. The initial term of the lease was four
months ending on May 31, 2022. The lease was renewed on June 1, 2022, and the
base rent is currently $6,300 per month.
In July 2022, the Company paid a related party, Taucoin Asset Management LLC,
additional amounts of $200,000 and $400,000 to develop and implement marketing
strategies for Company products.
Off-Balance Sheet Arrangements
We do not have any off-balance sheet arrangements that have or are reasonably
likely to have a current or future effect on our financial condition, changes in
financial condition, revenues or expenses, results of operations, liquidity,
capital expenditures, or capital resources that is material to investors.
Critical Accounting Policies
Our financial statements and related public financial information are based on
the application of accounting principles generally accepted in the United States
("GAAP"). GAAP requires the use of estimates; assumptions, judgments and
subjective interpretations of accounting principles that affect the reported
amounts of assets and liabilities, revenues and expenses and related disclosures
in our financial statements. We had no critical accounting policies for the year
ended December 31, 2021, or for the quarter ended September 30, 2022.
We have other key accounting policies, which involve the use of estimates,
judgments and assumptions that are significant to understanding our results,
which are summarized in Note 3 to our financial statements. Although we believe
that our estimates, judgments and assumptions are reasonable, they are based
upon information presently available. Actual results may differ from those
estimates.
© Edgar Online, source Glimpses